These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8718602)

  • 1. A comparison of active site binding of 4-quinolones and novel flavone gyrase inhibitors to DNA gyrase.
    Hilliard JJ; Krause HM; Bernstein JI; Fernandez JA; Nguyen V; Ohemeng KA; Barrett JF
    Adv Exp Med Biol; 1995; 390():59-69. PubMed ID: 8718602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of differential activities of ofloxacin enantiomers.
    Morrissey I; Hoshino K; Sato K; Yoshida A; Hayakawa I; Bures MG; Shen LL
    Antimicrob Agents Chemother; 1996 Aug; 40(8):1775-84. PubMed ID: 8843280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.
    Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinolone interactions with DNA and DNA gyrase.
    Shen LL
    Methods Mol Biol; 2001; 95():171-84. PubMed ID: 11089230
    [No Abstract]   [Full Text] [Related]  

  • 5. Mechanism of action of the des-F(6) quinolone BMS-284756 measured by supercoiling inhibition and cleavable complex assays.
    Wu P; Lawrence LE; Denbleyker KL; Barrett JF
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3660-2. PubMed ID: 11709365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing potential gyrase inhibitors of bacterial DNA gyrase: a comparison of the supercoiling inhibition assay and "cleavable complex" assay.
    Barrett JF; Bernstein JI; Krause HM; Hilliard JJ; Ohemeng KA
    Anal Biochem; 1993 Oct; 214(1):313-7. PubMed ID: 8250240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro cleavable-complex assay to monitor antimicrobial potency of quinolones.
    Walton L; Elwell LP
    Antimicrob Agents Chemother; 1988 Jul; 32(7):1086-9. PubMed ID: 2847641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
    Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
    J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unique biological properties and molecular mechanism of 5,6-bridged quinolones.
    Macinga DR; Renick PJ; Makin KM; Ellis DH; Kreiner AA; Li M; Rupnik KJ; Kincaid EM; Wallace CD; Ledoussal B; Morris TW
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2526-37. PubMed ID: 12878515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of action of quinolones against Escherichia coli DNA gyrase.
    Yoshida H; Nakamura M; Bogaki M; Ito H; Kojima T; Hattori H; Nakamura S
    Antimicrob Agents Chemother; 1993 Apr; 37(4):839-45. PubMed ID: 8388200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of quinolone inhibition of DNA gyrase. Appearance of unique norfloxacin binding sites in enzyme-DNA complexes.
    Shen LL; Kohlbrenner WE; Weigl D; Baranowski J
    J Biol Chem; 1989 Feb; 264(5):2973-8. PubMed ID: 2536729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.
    Revel-Viravau V; Truong QC; Moreau N; Jarlier V; Sougakoff W
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2054-61. PubMed ID: 8878580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolone mode of action--new aspects.
    Hooper DC
    Drugs; 1993; 45 Suppl 3():8-14. PubMed ID: 7689456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA gyrase of Staphylococcus aureus and inhibitory effect of quinolones on its activity.
    Takahata M; Nishino T
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1192-5. PubMed ID: 2847648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
    Nakada N; Gmünder H; Hirata T; Arisawa M
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by quinolones of DNA gyrase from Staphylococcus aureus.
    Tanaka M; Sato K; Kimura Y; Hayakawa I; Osada Y; Nishino T
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1489-91. PubMed ID: 1656864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
    Wu LC; Shahied SI
    Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of inhibition of DNA gyrase by ES-1273, a novel DNA gyrase inhibitor.
    Oyamada Y; Yamagishi J; Kihara T; Yoshida H; Wachi M; Ito H
    Microbiol Immunol; 2007; 51(10):977-84. PubMed ID: 17951987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87).
    Barnard FM; Maxwell A
    Antimicrob Agents Chemother; 2001 Jul; 45(7):1994-2000. PubMed ID: 11408214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two short peptides including segments of subunit A of Escherichia coli DNA gyrase as potential probes to evaluate the antibacterial activity of quinolones.
    Marchetto R; Nicolás E; Castillo N; Bacardit J; Navia M; Vila J; Giralt E
    J Pept Sci; 2001 Jan; 7(1):27-40. PubMed ID: 11245203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.